Pear Therapeutics Inc's ROI from its fourth quarter of 2022 to the fourth quarter of 2021 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Pear Therapeutics Inc's ROI in the fourth quarter of 2022?
Pear Therapeutics Inc recorded a cumulative net loss of $-75 million during 12 months ending in the fourth quarter of 2022, resulting in a negative return on investment (ROI) of -89.2%.

Within the Healthcare sector 921 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2022 from 0 to 5218.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Dec 31 2022) IV. Quarter	(Sep 30 2022) III. Quarter	(Jun 30 2022) II. Quarter	(Mar 31 2022) I. Quarter	(Dec 31 2021) IV. Quarter
Y / Y Investment Change TTM	-72.4 %	-61.97 %	-16.6 %	104.8 %	1297.3 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	46	72	96	126	150
Return On Investment (TTM)	-89.2 %	-27.43 %	-17.72 %	-26.71 %	-21.24 %
PEAR's Overall Ranking	# 5218	# 0	# 0	# 0	# 0
Seq. Investment Change TTM	-23.55 %	-36.59 %	-27.83 %	-21.11 %	5.34 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-75	-30	-31	-65	-65

PEAR Company Profile >> Back to PEAR Roi Comparisons >> See Annual PEAR Return On Investment

Return On Investment PEAR's Ranking
Within:	No.
Industry	# 207
Sector	# 922
Overall	# 5218

Return On Investment Statistics
High	Average	Low
2.77 %	-51.06 %	-101.84 %
		(Sep 30 2022)

Financial Statements
Pear Therapeutics Inc's IV. Quarter Investments	$ 46 Millions	PEAR's Balance sheet
Pear Therapeutics Inc's IV. Quarter Income	$ -26 Millions	Quarterly PEAR's Income Statement
PEAR's Income by Division		See PEAR's Income by Division

PEAR Annual Return On Investment	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Investments in Millions	46	150	0	0	0
Y / Y Investment Growth	-69.54 %	-	-	-	-
Net Income in Millions	-75	-65	0	0	0
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-165.24 %	-43.43 %	-	-	-

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
PEAR's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for PEAR's Competitors
Subscribers only: Roi for Pear Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for PEAR's Customers

Other Ratios
PEAR's Roa	PEAR's Inventory Turnover Ratio	PEAR's Growth Rates	PEAR's Dividend Statistics
	PEAR's Profitability Ratios	PEAR's Asset Turnover Ratio	PEAR's Dividend Growth
PEAR's Roe	PEAR's Valuation Ratios	PEAR's Financial Strength Ratios	PEAR's Dividend Payout Ratio

Companies with similar Return On Investment at Dec 31 2022, within Healthcare Sector

ROI

Date modified: 2026-09-08T15:22:10+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.